Human Fibrinogen EP Injection About
Experience a masterful solution with the new release Fibrinogen-I Human Fibrinogen EP Injection. Specially designed for the treatment and prevention of bleeding in patients with fibrinogen deficiency, this valuable hemostatic agent is derived from high-grade human plasma. For a limited time, purchase genuine 1G vials, expertly packaged for clinicians and hospital settings. Reconstitute the lofty lyophilized powder using the provided sterile water for safe intravenous administration. Approved for both adults and children, Fibrinogen-I offers trusted, effective plasma derivative therapy-secure your supply today.
Powerful Treatment for Bleeding Control - Usage & Applications
Human Fibrinogen EP Injection is vital for managing acquired or inherited fibrinogen deficiency. Its main use includes controlling and preventing bleeding episodes during surgeries or trauma. To prepare, reconstitute the lyophilized powder with sterile water as instructed before intravenous injection. It's suitable for adults and children following physician guidance. Each vial's administration ensures precise, measurable benefit, making it a sought-after therapeutic choice for clinical environments requiring critical hemostatic intervention.
Attractive Pricing and Expansive Market Reach - Payment & Supply
Fibrinogen-I Injection is available at a competitive sale price, ensuring market value for hospitals and clinical suppliers. We offer the lowest price for bulk purchases and flexible payment terms for domestic and international buyers. As a leading exporter, supplier, and trader based in India, our primary export markets span Asia, the Middle East, and Africa, with major distribution hubs serving both urban and regional Indian healthcare facilities to guarantee product availability and prompt delivery.
FAQ's of Human Fibrinogen EP Injection:
Q: How should Human Fibrinogen EP Injection be prepared before use?
A: Reconstitute the lyophilized powder with the sterile water provided before administering as an intravenous injection, following the guidelines in the packaging insert.
Q: What are the main therapeutic benefits of Fibrinogen-I Injection?
A: It effectively treats and prevents bleeding in patients with congenital or acquired fibrinogen deficiency, ensuring rapid and reliable hemostasis when timely clot formation is essential.
Q: When is it appropriate to administer Human Fibrinogen EP Injection?
A: This injection should be used during bleeding episodes, surgeries, or trauma in patients diagnosed with fibrinogen deficiency, strictly under medical supervision.
Q: Where can this product be used, and who can receive it?
A: Fibrinogen-I is approved for hospital and clinical use and may be administered to both adults and children, depending on clinical assessment and physician authorization.
Q: What side effects may occur with the use of this injection?
A: Possible side effects include allergic reactions, fever, or chills. Any adverse reactions should be reported immediately to a healthcare professional.
Q: What is the process for storing Human Fibrinogen EP Injection?
A: Store the vial below 25C, protect it from light, and keep it within the original packaging until it is ready for use, always checking for the expiry on the box.